Speed of Processing Training to Improve Cognition in Multiple Sclerosis
NCT ID: NCT02301260
Last Updated: 2020-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2014-04-30
2020-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Applying Speed of Processing Training to Individuals With Multiple Sclerosis
NCT01838824
Speed of Processing Training to Improve Cognition in Traumatic Brain Injury and Mild Cognitive Impairment
NCT02020564
Remote Exercise Effects on Cognitive Processing Speed in Multiple Sclerosis: A Pilot Trial
NCT05344040
Applying Speed of Processing Training to Individuals With Traumatic Brain Injury
NCT01838811
Treating Cognitive Deficits in Traumatic Spinal Cord Injury (SCI)
NCT03985540
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Speed of Processing Training (SPT)
SPT will be administered on a laptop computer twice a week for 5 weeks (10 training sessions).
Speed of Processing Training (SPT)
Placebo control group
Placebo control exercises will be administered on a laptop computer twice a week for 5 weeks (10 sessions)
Placebo Control
Placebo control exercises will be administered on a laptop computer twice a week for 5 weeks (10 training sessions).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Speed of Processing Training (SPT)
Placebo Control
Placebo control exercises will be administered on a laptop computer twice a week for 5 weeks (10 training sessions).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of Multiple Sclerosis
* processing speed impairment (based on evaluation)
Exclusion Criteria
* currently taking steroids or benzodiazepines
* history of significant psychiatric illness (bipolar disorder, schizophrenia, or psychosis) or a current diagnosis of Major Depressive Disorder
* significant alcohol or drug abuse history
18 Years
59 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Multiple Sclerosis Society
OTHER
Kessler Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nancy Chiaravalloti
Director, Neuropsychology and Neuroscience Laboratory
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nancy Chiaravalloti, PhD
Role: PRINCIPAL_INVESTIGATOR
Kessler Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kessler Foundation
West Orange, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Goverover Y, Costa S, DeLuca J, Chiaravalloti N. The Efficacy of the Speed of Processing Training Program in Improving Functional Outcome: From Restoration to Generalization. Arch Phys Med Rehabil. 2023 Jun;104(6):925-931. doi: 10.1016/j.apmr.2023.01.017. Epub 2023 Feb 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RG 4997A5/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.